Home › Funds › Sio Capital Management, LLC › DNTH

Sio Capital Management, LLC position in DNTH

DIANTHUS THERAPEUTICS INC · Health Care

Sio Capital Management, LLC reported holding 59,254 shares of DNTH (DIANTHUS THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$5.8M, representing 0.96% of its reported portfolio and ranking #33 among its reported holdings. Sio Capital Management, LLC has disclosed DNTH holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)59.25K sh
Reported value held$5.78M
Portfolio Weight0.96%
First reportedQ1 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Sio Capital Management, LLC's DNTH position evolved

Sio Capital Management, LLC first disclosed a stake in DNTH in Q1 2025 at 116,997 shares (US$2.1M). The position peaked in Q1 2026 at 370,045 shares, worth US$31.1M. Across 6 filings, Sio Capital Management, LLC increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 59,254 shares valued at US$5.8M — a reduction of -310,791 shares quarter over quarter.. Notable position changes include a 102% increase in Q2 2025 (shares rose 111% over the following quarter), a 145% increase in Q3 2025 (shares rose 5% over the following quarter), a 84% trim in Q2 2026 (shares fell 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 117.00K $2.12M New
Q2 2025 236.07K $4.40M Add
Q3 2025 577.75K $22.73M Add
Q4 2025 474.50K $19.55M Reduce
Q1 2026 370.05K $31.05M Reduce
Q2 2026 59.25K $5.78M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DNTH and 13F data

DNTH (DIANTHUS THERAPEUTICS INC) is a Health Care company. 73 other funds we track also report a position in DNTH — the largest reported positions include Fairmount Funds Management LLC (US$247.3M), Avidity Partners Management LP (US$205.1M), Octagon Capital Advisors LP (US$179.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DNTH

All DNTH fund holders →

FAQ

How long has Sio Capital Management, LLC held DNTH?

Sio Capital Management, LLC has disclosed DNTH holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is Sio Capital Management, LLC's current position in DNTH?

As of Q2 2026, Sio Capital Management, LLC holds 59.25K shares of DNTH (DIANTHUS THERAPEUTICS INC), valued at $5.78M, representing 0.96% of its reported portfolio and ranking #33.

Has Sio Capital Management, LLC been buying or selling DNTH?

In the latest 13F filing (Q2 2026), Sio Capital Management, LLC reduced its position in DNTH. The position peaked in Q1 2026 at 370.05K shares.

Which other funds hold DNTH?

Other major institutional holders of DNTH include Fairmount Funds Management LLC, Avidity Partners Management LP, Octagon Capital Advisors LP, among 73 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.